Bruno
Paiva
Profesional Investigador
National Cancer Institute
Rockville, Estados UnidosPublicaciones en colaboración con investigadores/as de National Cancer Institute (7)
2024
-
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma
Blood cancer discovery, Vol. 5, Núm. 3, pp. 146-152
2021
-
Minimal residual disease in Myeloma: Application for clinical care and new drug registration
Clinical Cancer Research, Vol. 27, Núm. 19, pp. 5195-5212
2016
-
Assessment of minimal residual disease in myeloma and the need for a consensus approach
Cytometry Part B - Clinical Cytometry, Vol. 90, Núm. 1, pp. 21-25
-
Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition
Cytometry Part B - Clinical Cytometry, Vol. 90, Núm. 1, pp. 26-30
-
Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting
Cytometry Part B - Clinical Cytometry, Vol. 90, Núm. 1, pp. 31-39
2014
-
Flow cytometry detection of minimal residual disease in multiple myeloma: Lessons learned at FDA-NCI roundtable symposium
American Journal of Hematology